Medical Minutes

Share

Program Content

Activities

  • Adjuvant Therapy for HR+HER2- Early Breast Cancer
    Selecting Adjuvant Therapy for Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 16, 2024

    Expires: September 15, 2025

Faculty

cover img faculity

Tanya Gupta, MD

Palo Alto Medical Foundation
Palo Alto, California

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Smart Patients

ProCE Banner